Comprehensive Financial Management’s Ginkgo Bioworks DNA Stock Holding History

Comprehensive Financial Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$175K	Hold	17,656	–	–	0.01%	37
2026 Q1	$108K	Hold	17,656	–	–	﹤0.01%	36
2025 Q4	$147K	Hold	17,656	–	–	﹤0.01%	35
2025 Q3	$257K	Hold	17,656	–	–	0.01%	38
2025 Q2	$199K	Hold	17,656	–	–	0.01%	41
2025 Q1	$101K	Hold	17,656	–	–	﹤0.01%	38
2024 Q4	$173K	Hold	17,656	–	–	﹤0.01%	38
2024 Q3	$144K	Sell	17,656 -2	-0%	-$20	﹤0.01%	40
2024 Q2	$236K	Hold	17,658	–	–	0.01%	39
2024 Q1	$819K	Hold	17,658	–	–	0.03%	30
2023 Q4	$1.19M	Hold	17,658	–	–	0.04%	25
2023 Q3	$1.28M	Hold	17,658	–	–	0.05%	27
2023 Q2	$1.31M	Hold	17,658	–	–	0.04%	29
2023 Q1	$939K	Hold	17,658	–	–	0.03%	32
2022 Q4	$1.19M	Buy	+17,658	New	+$1.62M	0.04%	31

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Comprehensive Financial Management's DNA Position: Q2 2026 in Review

Comprehensive Financial Management held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 17,656 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #37.

Comprehensive Financial Management first reported a position in DNA in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.31M in Q2 2023. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Comprehensive Financial Management held 17,656 shares of Ginkgo Bioworks worth $175K as of Q2 2026.
Comprehensive Financial Management left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up 0.01% of Comprehensive Financial Management's portfolio in Q2 2026, its #37 holding.
Comprehensive Financial Management first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 15 quarters since.
Comprehensive Financial Management's Ginkgo Bioworks position peaked at $1.31M in Q2 2023.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Comprehensive Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.